Probing the coordination of cell cycle progression and differentiation in hematopoietic stem cells
探讨造血干细胞细胞周期进程和分化的协调
基本信息
- 批准号:10687421
- 负责人:
- 金额:$ 53.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-07 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:ATAC-seqAdultBiological AssayBloodBlood CellsBone MarrowBone marrow failureCell CycleCell Cycle ProgressionCell Cycle RegulationCell Cycle StageCellsChIP-seqChromatinChromatin Remodeling FactorComputer AnalysisDataEmbryoEnvironmentGenerationsGeneticGenetic TranscriptionGoalsHematological DiseaseHematopoiesisHematopoieticHematopoietic SystemHematopoietic stem cellsHistonesHomeostasisImpairmentIn VitroIndividualInterferonsLabelLinkLocationMaintenanceMolecularNeoplasmsPathologicPathway interactionsPhasePhenotypePositioning AttributeProcessProductionPropertyReagentRecording of previous eventsReporterReportingRepressionResearchScaffolding ProteinSignal PathwaySignal TransductionStimulusStressTestingTherapeuticTimeTranscriptional ActivationWorkadult stem cellbasebone marrow failure syndromecdc Genesclinically relevantexperimental studygenome-widehematopoietic differentiationhematopoietic stem cell differentiationhematopoietic stem cell expansionhematopoietic stem cell self-renewalin vivomutantnovel markernovel therapeuticsprogramsresidenceresponseself-renewalsingle cell analysisstemstem cell functiontooltranscription factortranscriptomics
项目摘要
ABSTRACT
Hematopoietic stem cells (HSCs) generate all mature blood cells in adults. They remain quiescent at
homeostasis but when needed, can reenter the cell cycle to either self-renew or differentiate and replenish the
hematopoietic system. While the pathways governing HSC self-renewal are just being uncovered, what
dictates HSC differentiation remains largely elusive. Recent studies indicate that residence in discrete phases
of the cell cycle potentiates differentiation in embryonic and adult stem cells of different origins. However, the
impact of cell cycle residence on HSC differentiation has not been directly explored. Here, we report the
hematopoietic phenotypes elicited upon genetic inactivation of the chromatin modifier Sin3B. Sin3B serves as
a scaffold protein that tethers repressive activities to discrete loci by interacting with sequence-specific
transcription factors and histone modifiers. Through its ability to modulate transcription of cell cycle genes
Sin3B restricts progression through the early phases of the cell cycle. Sin3B-deleted HSCs retain their self-
renewal capacities, but they are unable to properly differentiate. The appropriate expression of lineage
specification transcription factors suggests that alterations of the chromatin landscape likely dictate the
defective differentiation in Sin3B-/- HSCs. Thus, Sin3B inactivation provides a unique opportunity to study the
processes linking cell cycle progression with the generation of a transcriptional environment permissive for
HSC differentiation. Our central hypothesis is that the ability of HSCs to differentiate is restricted to a discrete
window within the early phase of the cell cycle. We will test the possibility that loss of Sin3B induces spurious
progression through early stages of the cell cycle, which is incompatible with proper HSC differentiation, due to
alterations in the chromatin landscape. We propose here to: Establish whether Sin3B-dependent restriction of
cell cycle progression enables HSC differentiation (aim 1). Using cell cycle reporters, lineage tracing tools and
single cell transcriptomic analyses, we will leverage the phenotypes elicited upon Sin3B inactivation to
determine the functional relationship between cell cycle progression and differentiation in HSCs; and
Determine the molecular bases for Sin3B-dependent differentiation in HSCs (aim 2).Through chromatin
accessibility assays and genome-wide mapping of histone marks, we will determine the chromatin features that
enable HSCs to respond to pro-differentiation stimuli during cell cycle progression. Based on our preliminary
data, we will test the hypothesis that specific signaling pathways we found altered in Sin3B-/- HSCs, including
the tonic interferon response, modulate the ability of HSCs to differentiate. Our proposed work will define an
understudied molecular link between cell cycle progression and hematopoietic differentiation, pointing to
potential approaches to modulate HSC expansion and differentiation for therapeutic purposes.
抽象的
造血干细胞(HSC)产生成人所有成熟的血细胞。他们保持静止状态
体内平衡,但在需要时,可以重新进入细胞周期以自我更新或分化和补充
造血系统。虽然控制 HSC 自我更新的途径刚刚被发现,但什么是
表明 HSC 的分化在很大程度上仍然难以捉摸。最近的研究表明,离散阶段的居住
细胞周期的改变增强了不同来源的胚胎干细胞和成体干细胞的分化。然而,
细胞周期停留对 HSC 分化的影响尚未被直接探索。在此,我们报道
染色质修饰剂 Sin3B 基因失活后引发造血表型。 Sin3B 充当
一种支架蛋白,通过与序列特异性相互作用将抑制活性束缚于离散基因座
转录因子和组蛋白修饰剂。通过其调节细胞周期基因转录的能力
Sin3B 限制细胞周期早期阶段的进展。 Sin3B 删除的 HSC 保留其自身
更新能力,但他们无法正确区分。血统的恰当表达
规范转录因子表明染色质景观的改变可能决定
Sin3B-/- HSC 的分化缺陷。因此,Sin3B 失活提供了一个独特的机会来研究
将细胞周期进程与允许转录的环境的产生联系起来的过程
HSC分化。我们的中心假设是 HSC 的分化能力仅限于离散的
细胞周期早期阶段的窗口。我们将测试 Sin3B 丢失导致杂散的可能性
细胞周期早期阶段的进展,这与适当的 HSC 分化不相容,因为
染色质景观的改变。我们在此建议:确定是否依赖于 Sin3B 的限制
细胞周期进程促进 HSC 分化(目标 1)。使用细胞周期记者、谱系追踪工具和
单细胞转录组分析,我们将利用 Sin3B 失活引起的表型来
确定 HSC 细胞周期进程和分化之间的功能关系;和
确定 HSC 中 Sin3B 依赖性分化的分子基础(目标 2)。通过染色质
通过可及性测定和组蛋白标记的全基因组图谱,我们将确定染色质特征
使 HSC 在细胞周期进程中能够对促分化刺激做出反应。根据我们的初步
数据,我们将测试我们发现 Sin3B-/- HSC 中特定信号通路发生改变的假设,包括
强直性干扰素反应,调节 HSC 的分化能力。我们提出的工作将定义一个
细胞周期进程和造血分化之间的分子联系尚未得到充分研究,指出
调节 HSC 扩增和分化以达到治疗目的的潜在方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gregory David其他文献
Gregory David的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gregory David', 18)}}的其他基金
Targeting the HMGB1-TLR5 pathway to prevent senescence-induced metastasis in breast cancer.
靶向 HMGB1-TLR5 通路预防乳腺癌衰老诱导的转移。
- 批准号:
10599637 - 财政年份:2023
- 资助金额:
$ 53.86万 - 项目类别:
Regulation of Cellular Senescence and Oncogenic Transformation by Sin3B.
Sin3B 对细胞衰老和致癌转化的调节。
- 批准号:
8761315 - 财政年份:2013
- 资助金额:
$ 53.86万 - 项目类别:
Role of cell cycle withdrawal in restricting pancreatic cancer progression.
细胞周期退出在限制胰腺癌进展中的作用。
- 批准号:
8434831 - 财政年份:2012
- 资助金额:
$ 53.86万 - 项目类别:
Role of cell cycle withdrawal in restricting pancreatic cancer progression.
细胞周期退出在限制胰腺癌进展中的作用。
- 批准号:
8242551 - 财政年份:2012
- 资助金额:
$ 53.86万 - 项目类别:
Regulation of Cellular Senescence and Oncogenic Transformation by Sin3B.
Sin3B 对细胞衰老和致癌转化的调节。
- 批准号:
8040517 - 财政年份:2011
- 资助金额:
$ 53.86万 - 项目类别:
Regulation of Cellular Senescence and Oncogenic Transformation by Sin3B.
Sin3B 对细胞衰老和致癌转化的调节。
- 批准号:
8408763 - 财政年份:2011
- 资助金额:
$ 53.86万 - 项目类别:
Regulation of Cellular Senescence and Oncogenic Transformation by Sin3B.
Sin3B 对细胞衰老和致癌转化的调节。
- 批准号:
8591386 - 财政年份:2011
- 资助金额:
$ 53.86万 - 项目类别:
Regulation of Cellular Senescence and Oncogenic Transformation by Sin3B.
Sin3B 对细胞衰老和致癌转化的调节。
- 批准号:
8206479 - 财政年份:2011
- 资助金额:
$ 53.86万 - 项目类别:
相似国自然基金
基于动态信息的深度学习辅助设计成人脊柱畸形手术方案的研究
- 批准号:82372499
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
单核细胞产生S100A8/A9放大中性粒细胞炎症反应调控成人Still病发病及病情演变的机制研究
- 批准号:82373465
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SERPINF1/SRSF6/B7-H3信号通路在成人B-ALL免疫逃逸中的作用及机制研究
- 批准号:82300208
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Epigenetic control of spermatogonial stem cell self-renewal
精原干细胞自我更新的表观遗传控制
- 批准号:
10656855 - 财政年份:2023
- 资助金额:
$ 53.86万 - 项目类别:
Gene regulatory networks in early lung epithelial cell fate decisions
早期肺上皮细胞命运决定中的基因调控网络
- 批准号:
10587615 - 财政年份:2023
- 资助金额:
$ 53.86万 - 项目类别:
The role of EMT transcription factor Zeb2 in fetal hematopoiesis
EMT转录因子Zeb2在胎儿造血中的作用
- 批准号:
10604587 - 财政年份:2023
- 资助金额:
$ 53.86万 - 项目类别:
Human brain multi-omics to decipher major depression pathophysiology
人脑多组学破译重度抑郁症病理生理学
- 批准号:
10715962 - 财政年份:2023
- 资助金额:
$ 53.86万 - 项目类别: